Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic

被引：0
|
作者：
Luca Roncati
Monica Roncati
机构：
[1] University of Modena and Reggio Emilia,Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplantation, Oncology and Regenerative Medicine
[2] University of Modena and Reggio Emilia,Department of Biomedical, Metabolic and Neural Sciences
[3] Polyclinic Hospital,undefined
来源：
Journal of Public Health Policy | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：518 / 521
页数：3
相关论文
共 50 条
  • [41] US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine
    Dal-Re, Rafael
    VACCINE, 2021, 39 (08) : 1180 - 1182
  • [42] COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays
    Sung, Heungsup
    Roh, Kyoung Ho
    Hong, Ki Ho
    Seong, Moon-Woo
    Ryoo, Namhee
    Kim, Hyun Soo
    Lee, Jaehyeon
    Kim, So Yeon
    Yoo, Sookwon
    Kim, Mi-Na
    Han, Myung Guk
    Lee, Sang Won
    Lee, Hyukmin
    Yoo, Cheon Kwon
    ANNALS OF LABORATORY MEDICINE, 2020, 40 (06) : 439 - 447
  • [43] Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 (updated to Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19) (vol 54, pg 613, 2020)
    Piszczatoski, C. R.
    Powell, J.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (08) : 832 - 832
  • [44] Caring for cancer patients during COVID-19 global pandemic: Risk factors and precautionary principle
    Yashavantha Rao, H. C.
    Siddeeqh, Salman
    Taqui, Syed Noeman
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (06)
  • [45] THE PRINCIPLE OF UNITY AND INDIVISIBILITY OF THE REPUBLIC AT THE TIME OF EMERGENCY COVID-19
    Pagano, Fabio Francesco
    BIOLAW JOURNAL-RIVISTA DI BIODIRITTO, 2020, (01): : 209 - 218
  • [46] Post-emergency use authorization (EUA) active safety surveillance study among individuals in the veterans affairs health system receiving Pfizer-BioNtech coronavirus disease 2019 (COVID-19) vaccine
    Asomaning, Kofi
    Duh, Mei Sheng
    DerSarkissian, Maral
    De Luise, Cynthia
    Nguyen, Catherine
    Cheng, Mu
    Lax, Angela
    Park, Suna
    Guo, Mianzhao
    Zhang, Mingfang
    Cremieux, Pierre
    Young-Xu, Yinong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 483 - 483
  • [47] Post-emergency use authorization (EUA) active safety surveillance study among individuals in the veterans affairs health system receiving pfizer-biontech coronavirus disease 2019 (COVID-19) vaccine
    Asomaning, Kofi
    Duh, Mei Sheng
    DerSarkissian, Maral
    de Luise, Cynthia
    Nguyen, Catherine
    Cheng, Mu
    Lax, Angela
    Guo, Tracy
    Cunnington, Marianne
    Cremieux, Pierre Y.
    Young-Xu, Yinong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 172 - 173
  • [48] Novel recruitment, data collection, and safety reporting methods in the era of COVID-19: Design of a post-emergency use authorization COVID-19 vaccination safety-surveillance study
    OBrien, Emily
    Rubino, Heather
    Shostak, Jack
    Webb, Laura
    Cohen, Lauren
    Caubel, Patrick
    Mangum, Stacey
    Abernethy, Amy
    Wong, Cherise
    Kendrick, Katie
    Hernandez, Adrian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 448 - 449
  • [49] Marketing authorization of COVID-19 vaccines across UK, EU, and the US: fact-checking and the implications for future research
    Nasir Abbas
    Zaheer-Ud-Din Babar
    Journal of Pharmaceutical Policy and Practice, 14
  • [50] Marketing authorization of COVID-19 vaccines across UK, EU, and the US: fact-checking and the implications for future research
    Abbas, Nasir
    Babar, Zaheer-Ud-Din
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)
12345